Celltrion partners with US pharmacy chain for Yuflyma sales
Celltrion Healthcare, Celltrion's distribution unit, said Monday it has signed a deal with US specialty pharmacy chain CarePartners Pharmacy to sell its Humira biosimilar Yuflyma in the US market.
CarePartners Pharmacy is a national pharmacy that distributes medications across all 50 states and Washington DC, focusing on several niche programs, including autoimmune therapies.
Under the contract, Yuflyma will be distributed to drug stores operated by CarePartners Pharmacy nationwide, starting from the end of this month.
Celltrion said the partnership is expected to raise the presence of the Yuflyma autoimmune disease biosimilar among over 10 million patients in the US.
Yuflyma will be the only adalimumab sold at CarePartners Pharmacy drugstores as the US partner has decided not to sell AbbVie's blockbuster drug Humira and other competing biosimilars in the market.
Celltrion said it could ink the exclusive contract due to the drug's convenience both for patients and health care providers.
“Yuflyma uses a high concentration, citrate-free formulation, causing less pain when injected. The medication also comes with a latex-free injectable device, which can reduce allergy risk,” an official from Celltrion said.
Meanwhile, Celltrion Healthcare said the company will tap pharmacy benefit managers (PBMs), including Optum, to enlist Yuflyma in their formulary lists.
PBMs are companies that manage prescription drug benefits on behalf of health insurers. They negotiate fees and rebates with drug providers and create formulary lists of medications covered by insurance and reimburse pharmacies for patients' prescriptions.
Celltrion Healthcare said the company will increase its marketing efforts, with a goal of capturing around 40 percent share in the PBM market for adalimumab by the end of this year.
下一篇:Another suspect of Tajik duo behind S. Korean money exchange robbery nabbed
相关文章:
- Seoul subway workers vote for strike plan
- S. Korean industry minister visits Africa for World Expo bid, economic ties
- NewJeans hits 1 bln streams mark on Spotify with debut album
- Maestro Bychkov to debut in Korea with all
- Celltrion partners with US pharmacy chain for Yuflyma sales
- S. Korea wins gold in League of Legends competition; Faker tops podium
- S. Korea picks up 1st gold in roller skating
- Maestro Bychkov to debut in Korea with all
- Supporters of Israel hold rally in Seoul, urge Hamas to stop atrocities
- 2023 LoL World Championship to entertain esports fans
相关推荐:
- Celltrion partners with US pharmacy chain for Yuflyma sales
- N. Korea stipulates nuclear force
- Tving streams 2023 MTV VMAs
- N.Korea could use nuclear weapons at any stage of conflict: Pentagon
- TvN Sports, CGV to screen Bundesliga’s first ‘Korean derby’
- Yoon hosts luncheon meeting with Korean atomic bomb victims in Hiroshima on Chuseok
- Lotte names ex
- Explore the culture of Joseon during Chuseok
- Beef prices have soared 100
- N.Korea could use nuclear weapons at any stage of conflict: Pentagon
- [view] 민심 더 싸늘해지는데…감동 없는 김기현 2기
- Another suspect of Tajik duo behind S. Korean money exchange robbery nabbed
- USS Carl Vinson deploys for Indo
- TvN Sports, CGV to screen Bundesliga’s first ‘Korean derby’
- 이준석, 눈물의 회견…尹대통령 향해 "與 묵언 수행 저주 풀라"
- [Contribution] Why hope matters in climate crisis
- 김성원 여의도연구원장 "공천장사 지라시, 허위사실 유포로 고소"
- S. Korea set to open largest
- Seoul shares open higher on US gains
- S. Korea, US, Japan install trilateral communication hotline amid N. Korea, China challenges
- [Korea Beyond Korea] Early Koreanists on verge of extinction overseas
- Hyundai Motor may sell Russian plant to local firm
- [Herald Interview] Kim Jee
- S. Korea to step up quarantine efforts against animal diseases
- 카메라 찍힌 김여정 960만원 '디올 백'…그 자체가 北인권 참상
- [Feature] The rise and fall of terrestrial TV dramas